Service is in preparation Official β release coming soon. Some features are still being adjusted.

Investical Earnings & investing calendar Earnings & investing calendar
/
HHOSHIIRYO-SANKI CO.,LTD. logo
7634TSE Standard

HOSHIIRYO-SANKI CO.,LTD.

星医療酸器 Yahoo Finance

Recent & upcoming events

Aug 7
Earnings 2:00
Q1 earnings announcement (scheduled)
Add to Google Calendar
Jun 24
Shareholder meeting 21:00
Shareholders' meeting
Venue: 株式会社星医療酸器 本社会議室／東京都足立区入谷七丁目11番18号 Details
Add to Google Calendar
May 11
Earnings 2:00
FY earnings announcement (scheduled)
Add to Google Calendar
Sep 27
Est.
Dividend Time TBD
Last day with rights (interim)
Add to Google Calendar
Sep 28
Est.
Ex-dividend Time TBD
Ex-rights date (interim)
Add to Google Calendar
Nov 6
Est.
Earnings 1:00 approx.
Q2 earnings
Add to Google Calendar
2027
Jan 29
Est.
Earnings 1:00 approx.
Q3 earnings
Add to Google Calendar
Mar 28
Est.
Dividend Time TBD
Last day with rights (year-end)
Add to Google Calendar
Mar 29
Est.
Ex-dividend Time TBD
Ex-rights date (year-end)
Add to Google Calendar
Apr 30
Est.
Earnings 2:00 approx.
Full-year earnings
Add to Google Calendar
Jul 23
Est.
Earnings 2:00 approx.
Q1 earnings
Add to Google Calendar

KPI highlights

FY26
Revenue ¥15.52B YoY +2.8%
Operating income ¥1.92B margin 12.4%
Net income ¥1.37B YoY -6.2%
EPS ¥440 YoY -6.3%
P/E —
ROE 7.1% Equity ratio 75% Typical equity ratios vary a lot by industry. Banks, brokerages, and other financial companies tend to run lower ratios because leverage (using other people's capital) is core to their business model — a low ratio there isn't a sign of financial weakness.

Company guidance

FY2027/03 Company-issued full-year guidance (from earnings report) / %=vs prior FY
Revenue ¥15.66B +0.9%
Operating income ¥1.98B +3.2%
Net income ¥1.40B +2.0%
EPS ¥448 +2.0%

Quarterly fundamentals

Income & cash flow
Quarter FY22 Q4FY23 Q1FY23 Q2FY23 Q3FY23 Q4FY24 Q1
Revenue ¥3.35B¥3.94B¥3.34B¥3.63B¥3.68B¥4.13B
Operating income ¥451M¥521M¥395M¥484M¥518M¥566M
Net income ¥315M¥385M¥275M¥348M¥378M¥410M
Operating CF ——————

Ownership over time

Share of total shares outstanding (disclosed major holdings + undisclosed)（2021–2026）

事業法人 24.6%個人 32.1%未開示 43.3%202120222023202420252026
事業法人海外機関個人未開示・浮動株

「国内機関」は信託銀行の名義口座（年金・パッシブ・一部海外資本を含む）を集計し、実質保有者へは分解していません。分類は開示名称からの推定です。

Top shareholders — rank & share

星医療酸器取引先持株会 18.5%星医療酸器取引先持株会株式会社UH　Partners 2 7.5%株式会社UH　Partners 2光通信株式会社 6.8%光通信株式会社一星社株式会社 6.4%一星社株式会社星　　　幸　男 4.7%星　　　幸　男星　　　孝　子 3.5%星　　　孝　子星　　　昌　成 3.2%星　　　昌　成星医療酸器従業員持株会 2.2%星医療酸器従業員持株会株式会社UH　Partners 3 2%株式会社UH　Partners 3小池酸素工業株式会社 1.9%小池酸素工業株式会社202120222023202420252026

Top shareholders — actual figures (as of 2026)

Holder Shares held Ratio Source
星医療酸器取引先持株会 576,000 18.5% Yuho (EDINET)
株式会社UH Partners 2 234,000 7.5% Yuho (EDINET)
光通信株式会社 213,000 6.8% Yuho (EDINET)
一星社株式会社 200,000 6.4% Yuho (EDINET)
星 幸 男 148,000 4.7% Yuho (EDINET)
星 孝 子 110,000 3.5% Yuho (EDINET)
星 昌 成 100,000 3.2% Yuho (EDINET)
星医療酸器従業員持株会 67,000 2.2% Yuho (EDINET)
株式会社UH Partners 3 63,000 2.0% Yuho (EDINET)
小池酸素工業株式会社 59,000 1.9% Yuho (EDINET)

Source：EDINET（大株主の状況）　Classification inferred from disclosed names

F-Score (Piotroski)

5/9

Checks financial health against 9 criteria and shows how many are met as a fraction (more ✓ marks is healthier). Items with no data are shown as “—” — they're simply excluded from judgment, not counted against the score.

✓ Positive ROA ROA 5.1%
✓ Positive operating cash flow ¥2.48B
✗ ROA improved YoY 6.0% → 5.1%
✓ Operating CF exceeds net income (accrual quality) OCF ¥2.48B / net income ¥1.37B
✗ Equity ratio improved* Substitute for the original “decrease in long-term debt” 74.9% → 74.8%
✓ Current ratio improved 3.17× → 3.17×
✓ No dilution (shares outstanding did not increase) 3,420,000 → 3,420,000
✗ Gross margin improved 50.1% → 49.5%
✗ Asset turnover improved 0.61× → 0.58×

This score is reference information based on our own financial metrics. It is NOT a credit rating issued by a credit rating agency under Article 66-27 of the Financial Instruments and Exchange Act, and is NOT investment advice or a recommendation. Make investment decisions at your own responsibility.

Fact checklist

FY26
Equity ratio 74.8%
Current ratio 3.2×
Years of positive operating CF 10 of last 10 yrs
Payout ratio 21%
Latest fiscal year result Profit (net income ¥1.37B)

Performance history

Last 10 years
0億円39億円78億円116億円155億円 FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26

Income & assets

Unit: ¥100M
Item FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
Revenue 101104108109118128138148151155
Operating income 12.212.513.010.414.416.017.819.619.819.2
Ordinary income 12.712.713.210.814.616.218.220.420.520.0
Net income 7.988.628.717.359.9411.112.514.014.613.7
Total assets 151161168174190203212230246267
Equity 112120126130135145156174187203

Indicators & cash flow

Unit: ¥100M
Item FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
EPS ¥241¥261¥264¥225¥313¥358¥403¥451¥469¥440
ROE 7.5%7.6%7.2%5.8%7.6%8.0%8.5%8.7%8.2%7.1%
Operating CF 12.014.318.714.624.819.722.924.021.924.8
Investing CF -2.47-3.85-7.54-13.8-0.64-6.90-10.6-7.45-52.8-15.4
Financing CF -5.88-6.37-6.76-8.82-14.4-9.37-9.58-9.03-7.40-9.48
FCF 9.4910.411.20.8424.212.812.316.5-30.99.33

Source: EDINET (Annual Securities Report) (fetched 2026-08-29) *Some metrics supplemented from additional sources

Key financial metrics

3-year revenue growth ✓

Sector positioning

Relative standing within the sector
Is this information incorrect?

Data provided by Twelve Data